Alpha 2.0
Login Register
» Authors » Shawnda Tench

Shawnda Tench

Explore the profile of Shawnda Tench including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 430
Followers 0
Related Specialties
Hematology
Oncology
General Medicine
Top 10 Co-Authors
Ronald Sobecks
Lisa Rybicki
Matt Kalaycio
Robert Dean
Brad Pohlman
Steven Andresen
Brian J Bolwell
Edward Copelan
Brian T Hill
John Sweetenham
Published In
Biol Blood Marrow Transplant
Leuk Lymphoma
JAMA
Br J Haematol
Affiliations
Soon will be listed here.
Recent Articles
1.
Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial
Fowler 3rd A, Truwit J, Hite R, Morris P, DeWilde C, Priday A, et al.
JAMA . 2019 Oct; 322(13):1261-1270. PMID: 31573637
Importance: Experimental data suggest that intravenous vitamin C may attenuate inflammation and vascular injury associated with sepsis and acute respiratory distress syndrome (ARDS). Objective: To determine the effect of intravenous...
2.
Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT)
Bejanyan N, Bolwell B, Lazaryan A, Rybicki L, Tench S, Duong H, et al.
Biol Blood Marrow Transplant . 2011 Nov; 18(6):874-80. PMID: 22040844
Patient readmission within 30 days from discharge has been perceived by the Centers for Medicare and Medical Services as an indicator of poor healthcare quality for specific high-cost medical conditions....
3.
Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma
Hill B, Rybicki L, Smith S, Dean R, Kalaycio M, Pohlman B, et al.
Leuk Lymphoma . 2011 Feb; 52(6):986-93. PMID: 21314484
Hyper-CVAD (fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate) is an intense chemotherapy regimen frequently used for hematologic malignancies including mantle cell lymphoma. To address whether treatment...
4.
The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls
Hill B, Rybicki L, Bolwell B, Smith S, Dean R, Kalaycio M, et al.
Br J Haematol . 2011 Jan; 152(5):561-9. PMID: 21223255
High dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the preferred treatment modality for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). To assess long-term outcomes...
5.
Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remission
Sproat L, Bolwell B, Rybicki L, Tench S, Chan J, Kalaycio M, et al.
Leuk Lymphoma . 2010 Jul; 51(9):1699-704. PMID: 20629524
Patients with acute myeloid leukemia (AML) with intermediate or high risk cytogenetics are often considered for allogeneic hematopoietic stem cell transplant (AHSCT) in first remission. Between attainment of remission and...
6.
Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants
Hill B, Bolwell B, Rybicki L, Dean R, Kalaycio M, Pohlman B, et al.
Biol Blood Marrow Transplant . 2010 Jun; 16(12):1738-46. PMID: 20558313
Allogeneic hematopoietic stem cell transplantation (SCT) for patients who have previously undergone allogeneic or autologous SCT is potentially curative, but dangerous. To identify patient, disease, and treatment characteristics associated with...